PRFX: PainReform Corp Operating Profitability

Brandmark of PainReform (PRFX)

PainReform Ltd. invests in biopolymers to create analgesic delivery systems. Examining the operating margin on GURU.Markets, we see that -16629.00 serves as the current value of the parameter. The company's technology eliminates opioids, addressing the social issues of addiction. Business dynamics rely on the success of clinical trials and the US launch, remaining independent of macroeconomic fluctuations.

PRFX: painreform.com Operating Return on Sales 07/04/2022 - 11/19/2026

Metric breakdowns and analytics for painreform.com (PRFX)

Fundamental company valuation:PRFX, PainReform Corp
Core merchandise of PainReform Ltd.

For the biotechnology company PainReform Ltd. (PRFX), which is in the clinical trial stage without active sales, the operating margin serves as an indicator of the efficiency of managing drug development costs. By analyzing this operating margin chart, an investor assesses the ratio of operating profit to revenue, which, given the issuer's current lack of pricing power, allows for the tracking of the capital burn rate prior to product commercialization.

Analysis of competing companies

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|LYRA (Lyra Therapeutics) - Operating Profitability|Operating Profitability Impact BioMedical Inc|TNF Pharmaceuticals - Operating Profit Margin|Operating Margin YCBD|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.